The Pennant Group, Inc. (PNTG) Stock Grade

About The Pennant Group, Inc.'s fundamentals

The Pennant Group has achieved strong revenue growth of 36.3% year-over-year, demonstrating expanding operational scale within the medical care facilities sector. However, the company operates with a thin net margin of 3.1%, indicating modest profitability relative to sales, and generates an 8.9% return on equity that is below typical benchmarks for established healthcare operators. The stock trades at a P/E ratio of 32.9, which reflects investor expectations for future earnings growth, and the company does not currently pay a dividend.